Abstract:Background The role and mechanism of the nicotinamide adenine dinucleotide (NAD(+)) salvage pathway in cancer cell proliferation is poorly understood. Nicotinamide phosphoribosyltransferase (NAMPT), which converts nicotinamide into NAD(+), is the rate-limiting enzyme in the NAD(+) salvage pathway. Here, we assessed the role of NAMPT in the proliferation of colorectal cancer. Methods Real-time PCR, immunohistochemistry, western blotting, and analyses of datasets from Oncomine and Gene Expression Omnibus were conducted to assess the expression of NAMPT at the mRNA and protein levels in colorectal cancer. The Kaplan Meier plotter online tool was used to evaluate the prognostic role of NAMPT. Knockdown of NAMPT was performed to assess the role of NAMPT in colorectal cancer cell proliferation and tumorigenesis both in vitro and in vivo. Overexpression of NAMPT was used to evaluate impact of NAMPT on colorectal cancer cell proliferation in vitro. NAD(+) quantitation, immunofluorescence, dual luciferase assay and western blot were used to explore the mechanism of colorectal cancer proliferation. Transwell migration and invasion assays were conducted to assess the role of NAMPT in cell migration and invasion abilities of colorectal cancer cells. Results Our study indicated that the inhibition of NAMPT decreased proliferation capacity of colorectal cancer cells both in vitro and in vivo. Conversely, overexpression of NAMPT could promote cell proliferation in vitro. NAMPT inhibition induced beta-catenin degradation by increasing Axin expression levels; this resulted in the inhibition of Wnt/beta-catenin signaling and cell proliferation in colorectal cancer. The addition of nicotinamide mononucleotide, the enzymatic product of NAMPT, effectively reversed beta-catenin protein degradation and inhibited growth. Similarly, the knockdown of Axin also decreased the cell death induced by the inhibition of NAMPT. In addition, we showed that colorectal cancer tissues harbored significantly higher levels of NAMPT than the levels harbored by paired normal tissues, especially in colorectal cancer stages I and II. And the overexpression of NAMPT was associated with unfavorable survival results. Conclusions Our findings reveal that NAMPT plays an important role in colorectal cancer proliferation via Wnt/beta-catenin pathway, which could have vital implications for the diagnosis, prognosis and treatment of colorectal cancer.

Endoscopic observations of blocked ventriculoperitoneal (VP) shunt

Nicotinamide N -methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization

NAMPT: A critical driver and therapeutic target for cancer

Cytomegalovirus vaccine virus (Towne strain) does not induce latency.

Nicotinamide N-methyltransferase Enhances the Capacity of Tumorigenesis Associated with the Promotion of Cell Cycle Progression in Human Colorectal Cancer Cells.

Spectropolarimetry of stripped-envelope supernovae: observations and modelling

Nicotinamide N-methyltransferase enhances resistance to 5-fluorouracil in colorectal cancer cells through inhibition of the ASK1-p38 MAPK pathway.

Targeting the NAD<SUP>+</SUP> salvage pathway suppresses APC mutation-driven colorectal cancer growth and Wnt/-catenin signaling via increasing Axin level

Nicotinamide Phosphoribosyl Transferase Regulates Cell Growth Via the Sirt1/P53 Signaling Pathway and is a Prognosis Marker in Colorectal Cancer

Recent advances of targeting nicotinamide phosphoribosyltransferase (NAMPT) for cancer drug discovery

Regulative Effect of Nampt on Tumor Progression and Cell Viability in Human Colorectal Cancer

Identification of novel resistance mechanisms to NAMPT inhibition via the de novo NAD+ biosynthesis pathway and NAMPT mutation

NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma

Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) in cancer: a patent review

The response of flow-triggered infant ventilators.

NAD pool as an antitumor target against cancer stem cells in head and neck cancer

Targeting NAD+ Metabolism: Preclinical Insights into Potential Cancer Therapy Strategies

Ott_a_282367 187..198

Structural Basis for Resistance to Diverse Classes of Nampt Inhibitors

Neutralization of “Long-Acting Thyroid Stimulator” of Graves' Disease by Antisera to Bovine Pituitary Thyrotropin.∗

Drug Discovery Targeting Nicotinamide Phosphoribosyltransferase (NAMPT): Updated Progress and Perspectives